Match!
Hiroki Izumi
Tottori University
CancerPathologyLung cancerCancer researchMedicine
21Publications
5H-index
54Citations
What is this?
Publications 21
Newest
#1Hiroki Izumi (Tottori University)H-Index: 5
#2Masahiro Kodani (Tottori University)H-Index: 8
Last. Akira Yamasaki (Tottori University)H-Index: 16
view all 16 authors...
Immune checkpoint inhibitors (ICIs), including nivolumab, have exhibited substantial benefits in the treatment of several types of cancers. However, treatment with ICIs is often accompanied by immune-related adverse events (irAEs), and a clear understanding of the precise indications and management of irAEs is important for harnessing the full potential of these agents. While skin- or gastrointestinal-associated irAEs have been relatively well studied, there are few reports regarding nivolumab-i...
Source
#1Akira Yamasaki (Tottori University)H-Index: 16
#2Tomoya Harada (Tottori University)H-Index: 10
Last. Takahiko Horiguchi (Kindai University)
view all 11 authors...
#1Hiroki Izumi (Tottori University)H-Index: 5
#2Akira Yamasaki (Tottori University)H-Index: 16
Last. Eiji Shimizu (Tottori University)H-Index: 31
view all 14 authors...
Abstract Objectives Zoledronate (ZOL) is usually used for prevention of skeletal-related events in cancer patients with bone metastases. The first administration of ZOL is occasionally associated with development of acute-phase reaction (APR), which is due to activation of γδ T cells. ZOL-related APR was associated with better overall survival (OS) of patients with non-small cell lung cancer (NSCLC) in our previous retrospective study. However, it remains to be clarified whether γδ T cells are m...
2 CitationsSource
#1Hiroki Izumi (Tottori University)H-Index: 5
#2Akira Yamasaki (Tottori University)H-Index: 16
Last. Eiji Shimizu (Tottori University)H-Index: 31
view all 7 authors...
6 CitationsSource
Source
#1K. YamaneH-Index: 1
#2Kenichi TakedaH-Index: 11
Last. S. Eiji
view all 10 authors...
Source
#1Hiroki Izumi (Tottori University)H-Index: 5
#2Tadashi Igishi (Tottori University)H-Index: 18
Last. Eiji Shimizu (Tottori University)H-Index: 31
view all 13 authors...
: Nitrogen-containing bisphosphonates (N-BPs), which are usually used for the treatment of advanced cancer with bone metastasis, occasionally cause fever following the first administration. However, it is unclear as to how the development of fever following the first administration of N-BP is associated with clinical outcome. The aim of the present study was to determine the prognostic value of the development of fever following the first administration of N-BP in advanced non-small cell lung ca...
1 CitationsSource
#1Hiroki Izumi (Tottori University)H-Index: 5
#2Masahiro Kodani (Tottori University)H-Index: 8
Last. Eiji Shimizu (Tottori University)H-Index: 31
view all 6 authors...
: A 51-year-old man was diagnosed with colon cancer in September 2011, and a solitary pulmonary nodule was detected by computed tomography (CT) scan. We performed a transbronchial biopsy with endobronchial ultrasonography using a guide sheath (GS) and diagnosed lung metastasis of colon cancer. The patient experienced remittent fever after the biopsy in spite of intravenous antibiotic therapies. Moreover, his CT scan showed a large lung abscess at the biopsy site. We performed transbronchial drai...
1 CitationsSource
#1Kenichi Takeda (Tottori University)H-Index: 11
#2Akira Yamasaki (Tottori University)H-Index: 16
Last. Eiji Shimizu (Tottori University)H-Index: 31
view all 16 authors...
Background: Chronic obstructive pulmonary disease is a smoking-related disease, and is categorized into the emphysema and airway dominant phenotypes. We examined the relationship between emphysematous changes and epidermal growth factor receptor (EGFR) mutation status in patients with lung adenocarcinoma. Patients and Methods: The medical records for 250 patients with lung adenocarcinoma were retrospectively reviewed. All patients were categorized into the emphysema or non-emphysema group. Resul...
2 CitationsSource
#1Hiroki Izumi (Tottori University)H-Index: 5
#2Jun Kurai (Tottori University)H-Index: 12
Last. Eiji Shimizu (Tottori University)H-Index: 31
view all 9 authors...
Pulmonary alveolar microlithiasis (PAM) is a rare autosomal recessive disease caused by mutations in SLC34A2 and characterized by intra-alveolar accumulation of microliths. We diagnosed a case of PAM in a 27-year-old Japanese female and identified a novel mutation in SLC34A2 (c.1390 G>C [G464R] in exon 12).
6 CitationsSource
123